nejm tirzepatide osa in Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Disease Modification? Tirzepatide (Zepbound) – A New

These combined effects help improve glycaemic control and often result in weight loss, which has led to its increasing use in clinical practice

The researchers employed an eight-week dose escalation regimen at the start of treatment, with dose escalation (as tolerated) from 0.25mg/week for four weeks to 0.5mg for four weeks, followed by a maintenance dose of 1mg/week throughout the remainder of the treatment period, as they stated in their article

This allows researchers to determine the probes dynamic range and calculate the degree of oxidation in living cells

10.3390/nu17182930 Nutrients

The direction does not